abstract |
The present invention relates to a new pharmaceutical composition comprising citalopram, i.e. 1- [3- (dimethylamino) propyl] -1- (4-fluorophenyl) -1,3-dihydro-5-isobenzofurancarbonitrile. The pharmaceutical compositions of the present invention are solid dosage units comprising citalopram which are prepared by direct compression of the citalopram base, or a pharmaceutically acceptable salt thereof, and by direct compression of the carrier and / or other excipient commonly used in the manufacture of the medicament. According to the invention, pharmaceutically acceptable salts of citalopram can be prepared in the form of large crystals. HE |